The Prescription Only Medicines (Human Use) Amendment Order 1997

Amendment of Schedule 1 to the principal Order

2.  In Schedule 1 to the principal Order (which specifies substances which if included in medicinal products make those products prescription only medicines and exemptions from restrictions on the sale and supply of prescription only medicines)

(a) in the entry for “Carbenoxolone Sodium”, there is substituted for “506mg” in column 5, “560mg”;

(b) the entry for “Terfenadine” is amended by the deletion of the entries “120mg (MDD)” in column 4 and “Container or package containing not more than 1,200mg of Terfenadine” in column 5; and

(c) there are inserted in column 1 and, as the case may be, columns 2, 3 and 5, at the appropriate point in the alphabetical order of the entries as they appear in column 1, each of the entries set out in column 1 of Schedule 1 to this Order, together with the corresponding text in columns 2, 3 and 5 respectively of that Schedule.